Physician profile
Cordell Mitchell
NPI 1306899679
$1,081.50
in general payments reported to CMS, 2019-2025
12 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $12.69 · 2021: $90.54 · 2023: $191 · 2024: $258 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $400 · Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $400.00 |
| Food and Beverage | $290.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $400.00 | 2024-2025 | |
| Gauss Surgical INC. | $99.87 | 2019 | |
| Smith+Nephew, INC. | $97.69 | 2019 | |
| Pfizer INC. | $86.51 | 2021-2024 | |
| Myriad Women'S Health, INC. | $83.63 | 2023 | Myrisk |
| Astellas Pharma US INC | $71.62 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $70.37 | 2020-2023 | Slynd, Nuvessa |
| Abbvie INC. | $41.41 | 2019-2025 | |
| Shield Therapeutics INC | $40.42 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $38.94 | 2019 | |
| Hologic Sales and Service, LLC | $34.20 | 2019 | |
| Sumitomo Pharma America, INC. | $16.84 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cordell Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.